ScholarIQanswers from OpenAlex

Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety

PaperCitations, authors & open-access status

Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety have?

ScholarIQcitation count

Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety published?

ScholarIQyear

Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety has 2022 year in the ScholarIQ index.

What is the open-access status of Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety?

ScholarIQoa status

Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety has gold oa status in the ScholarIQ index.

What is the DOI of Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety?

ScholarIQdoi

The DOI for Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety is on the source record.

What is the PMID of Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety?

ScholarIQpmid

The PMID for Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety is on the source record.

What is the OpenAlex record for Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety?

ScholarIQopenalex

The OpenAlex for Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial